Phycocyanin Induces Apoptosis and Enhances the Effect of Topotecan on Prostate Cell Line LNCaP
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
C-phycocyanin (C-PC) from Spirulina has been previously shown to have anticancer properties. Here, we report on anticancer activity of C-PC that was isolated from the novel cyanobacterium Limnothrix sp. 37-2-1. C-PC from this organism exhibited anticancer properties in our in vitro systems; however, the required doses were well above the range of anticancer drugs normally used. Therefore, we conducted several experiments to test whether lower-than-usual doses of the anticancer drug topotecan (TPT) can offer the same level of cytotoxic effects as normal doses when combined with C-PC. For this purpose, cytotoxicities of C-PC and TPT were tested using the LNCaP (prostate cancer) cells. We found that when only 10% of a typical dose of TPT was combined with C-PC, the cancer cells were killed at a higher rate than when TPT was used alone at full dose. Similarly, we were also able to detect an increased level of radical oxygen species (ROS) generation as well as an increase in activities of caspase-9 and caspase-3 when these two compounds were used in combination. Taken together, our findings suggest that combining C-PC from Limnothrix sp. with the lower dose of TPT can induce apoptosis through generation of ROS and activation of caspases. In that respect, we suggest that C-PC can potentially improve the efficacy of the currently available anticancer drug, and therefore diminish its harsh side effects in the patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current knowledge on potential health benefits of Spirulina
Belay, A., Ota, Y., Miyakawa, K., & Shimamatsu, H. (1993) · Journal of Applied Phycology · doi:10.1007/bf00004024 · Cited by 465 · cited 1×
“6,7 It has been suggested that stimulation of the immune system by phycocyanin was a mechanism that inhibited the growth of tumor cells.”
Luesch, H., Yoshida, W. Y., Moore, R. E., Paul, V. J., & Corbett, T. H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010453j · Cited by 373
Trimurtulu, G., Ohtani, I., Patterson, G. M. L., Moore, R. E., Corbett, T. H., Valeriote, F. A., & Demchik, L. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00090a020 · Cited by 303
Inhibitory effect of phycocyanin from Spirulina platensis on the growth of human leukemia K562 cells
Liu, Y., Xu, L., Cheng, N., Lin, L., & Zhang, C. (2000) · Journal of Applied Phycology · doi:10.1023/a:1008132210772 · Cited by 120 · cited 2×
“Liu et al. 8 also reported on antineoplastic activity of phycocyanin isolated from Spirulina .”
Cited by
Phycobiliproteins from cyanobacteria: Chemistry and biotechnological applications
Pagels, F., Guedes, A. C., Amaro, H. M., Kijjoa, A., & Vasconcelos, V. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.010 · Cited by 426
Phycobiliprotein: Potential microalgae derived pharmaceutical and biological reagent
Manirafasha, E., Ndikubwimana, T., Zeng, X., Lu, Y., & Jing, K. (2016) · Biochemical Engineering Journal · doi:10.1016/j.bej.2016.01.025 · Cited by 321
Therapeutic Uses of Red Macroalgae
Ismail, M. M., Alotaibi, B. S., & EL-Sheekh, M. M. (2020) · Molecules · doi:10.3390/molecules25194411 · Cited by 118
Anti-Oxidation Properties and Therapeutic Potentials of Spirulina
Han, P., Li, J., Zhong, H., Xie, J., Zhang, P., Lu, Q., Li, J., Xu, P., Chen, P., Leng, L., et al. (2021) · Algal Research · doi:10.1016/j.algal.2021.102240 · Cited by 109
Microalgae in Terms of Biomedical Technology: Probiotics, Prebiotics, and Metabiotics
Oleskin, A. V., & Boyang, C. (2022) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683822060126 · Cited by 27
Metadata
- Authors
- Gantar, M., Dhandayuthapani, S., & Rathinavelu, A.
- Venue
- Journal of Medicinal Food
- Publisher
- SAGE Publications
- Published
- 2012-12
- Volume
- 15
- Issue
- 12
- Pages
- 1091-1095
- ISSN
- 1096-620X (ISSN-L)
- 1557-7600
- OpenAlex
- W2075501972
- Cited by
- 92
- References
- 4
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.